Tracy E. Macaulay, PharmD

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, occurring in over 2% of the general population.

Millions of people in the United States require chronic anticoagulation to prevent thromboembolism secondary to chronic atrial fibrillation (AF), pulmonary hypertension, mechanical valve replacements, and other prothrombotic conditions.

Atrial fibrillation affects over 2.2 million Americans and is estimated to affect up to 10 million by 2050.